Patents Assigned to FXS Ventures, LLC
-
Patent number: 10595532Abstract: The present invention relates to improved ophthalmic solutions that employ select B vitamins; pyridoxine and its salts; and thiamine and its salts in order to more effectively preserve solutions and to reduce the degree to which cationic preservatives will deposit on contact lenses. Ophthalmic solutions are here understood to include contact lens treatment solutions, such as cleaners, soaking solutions, conditioning solutions and lens storage solutions, as well as wetting solutions and in-eye solutions for treatment of eye conditions.Type: GrantFiled: August 6, 2018Date of Patent: March 24, 2020Assignee: FXS VENTURES, LLCInventor: Francis X. Smith
-
Patent number: 10531663Abstract: The present invention relates to an ophthalmic solution comprising 0.00001 to 10.0 weight percent of a simple saccharide, at least 0.00001 weight percent of a preservative, and not more than about 0.2 percent by weight chloride. The simple saccharide is chosen from the group consisting of: inositol; mannitol; sorbitol; sucrose; dextrose; glycerin; propylene glycol; ribose; triose; tetrose; erythrose; threose; pentose; arabinose; ribulose; xylose; xylulose; lyxose; hexose; allose; altrose; fructose; galactose; glucose; gulose; idose; mannose; sorbose; talose; tagatose; adlose; ketose; heptose; sedoheptulose; monosaccharides; disaccharides; sugar alcohols; xylitol; and polyol.Type: GrantFiled: February 11, 2019Date of Patent: January 14, 2020Assignee: FXS Ventures, LLCInventor: Francis X. Smith
-
Patent number: 10244760Abstract: The present invention relates to an ophthalmic solution comprising 0.00001 to 10.0 weight percent of a simple saccharide, at least 0.00001 weight percent of a preservative, and not more than about 0.2 percent by weight chloride. The simple saccharide is chosen from the group consisting of: inositol; mannitol; sorbitol; sucrose; dextrose; glycerin; propylene glycol; ribose; triose; tetrose; erythrose; threose; pentose; arabinose; ribulose; xylose; xylulose; lyxose; hexose; allose; altrose; fructose; galactose; glucose; gulose; idose; mannose; sorbose; talose; tagatose; adlose; ketose; heptose; sedoheptulose; monosaccharides; disaccharides; sugar alcohols; xylitol; and polyol.Type: GrantFiled: January 26, 2018Date of Patent: April 2, 2019Assignee: FXS VENTURES, LLCInventor: Francis X. Smith
-
Patent number: 10138384Abstract: The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: where R1, R2, R3 and R4 are —H or low molecular weight radicals, and R5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.Type: GrantFiled: September 7, 2017Date of Patent: November 27, 2018Assignee: FXS Ventures, LLCInventor: Francis X. Smith
-
Patent number: 10064410Abstract: The present invention relates to improved ophthalmic solutions that employ select B vitamins; pyridoxine and its salts; and thiamine and its salts in order to more effectively preserve solutions and to reduce the degree to which cationic preservatives will deposit on contact lenses. Ophthalmic solutions are here understood to include contact lens treatment solutions, such as cleaners, soaking solutions, conditioning solutions and lens storage solutions, as well as wetting solutions and in-eye solutions for treatment of eye conditions.Type: GrantFiled: January 23, 2017Date of Patent: September 4, 2018Assignee: FXS VENTURES, LLCInventor: Francis X. Smith
-
Patent number: 9913474Abstract: The present invention relates to an ophthalmic solution comprising 0.00001 to 10.0 weight percent of a simple saccharide, at least 0.00001 weight percent of a preservative, and not more than about 0.2 percent by weight chloride. The simple saccharide is chosen from the group consisting of: inositol; mannitol; sorbitol; sucrose; dextrose; glycerin; propylene glycol; ribose; triose; tetrose; erythrose; threose; pentose; arabinose; ribulose; xylose; xylulose; lyxose; hexose; allose; altrose; fructose; galactose; glucose; gulose; idose; mannose; sorbose; talose; tagatose; adlose; ketose; heptose; sedoheptulose; monosaccharides; disaccharides; sugar alcohols; xylitol; and polyol.Type: GrantFiled: September 28, 2016Date of Patent: March 13, 2018Assignee: FXS Ventures, LLCInventor: Francis X. Smith
-
Patent number: 9783688Abstract: The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: where R1, R2, R3 and R4 are —H or low molecular weight radicals, and R5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.Type: GrantFiled: May 1, 2017Date of Patent: October 10, 2017Assignee: FXS VENTURES, LLCInventor: Francis X. Smith
-
Patent number: 9694099Abstract: The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: where R1, R2, R3 and R4 are —H or low molecular weight radicals, and R5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.Type: GrantFiled: January 14, 2016Date of Patent: July 4, 2017Assignee: FXS VENTURES, LLCInventor: Francis X. Smith
-
Patent number: 9669129Abstract: The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: where R1, R2, R3 and R4 are —H or low molecular weight radicals, and R5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.Type: GrantFiled: September 2, 2015Date of Patent: June 6, 2017Assignee: FXS VENTURES, LLCInventor: Francis X. Smith
-
Patent number: 9585394Abstract: The present invention relates to improved ophthalmic solutions that employ select B vitamins; pyridoxine and its salts; and thiamine and its salts in order to more effectively preserve solutions and to reduce the degree to which cationic preservatives will deposit on contact lenses. Ophthalmic solutions are here understood to include contact lens treatment solutions, such as cleaners, soaking solutions, conditioning solutions and lens storage solutions, as well as wetting solutions and in-eye solutions for treatment of eye conditions.Type: GrantFiled: February 29, 2016Date of Patent: March 7, 2017Assignee: FXS VENTURES, LLCInventor: Francis X. Smith
-
Patent number: 9492582Abstract: The present invention relates to an ophthalmic solution comprising 0.00001 to 10.0 weight percent of a simple saccharide, at least 0.00001 weight percent of a preservative, and not more than about 0.2 percent by weight chloride. The simple saccharide is chosen from the group consisting of: inositol; mannitol; sorbitol; sucrose; dextrose; glycerin; propylene glycol; ribose; triose; tetrose; erythrose; threose; pentose; arabinose; ribulose; xylose; xylulose; lyxose; hexose; allose; altrose; fructose; galactose; glucose; gulose; idose; mannose; sorbose; talose; tagatose; adlose; ketose; heptose; sedoheptulose; monosaccharides; disaccharides; sugar alcohols; xylitol; and polyol.Type: GrantFiled: December 19, 2006Date of Patent: November 15, 2016Assignee: FXS VENTURES, LLCInventor: Francis X. Smith
-
Patent number: 9492581Abstract: A contact lens solution comprising 0.001 to 10 weight percent or a preservative enhancer chosen from the group consisting of: inositol; mannitol; sorbitol; sucrose; dextrose; glycerin and propylene glycol; and at least 0.0001 weight percent of a cationic polymeric preservative, and where the concentration of chloride in said solution is less than 0.2 percent by weight.Type: GrantFiled: November 8, 2001Date of Patent: November 15, 2016Assignee: FXS VENTURES, LLCInventor: Francis X. Smith
-
Patent number: 9415132Abstract: The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: where R1, R2, R3 and R4 are —H or low molecular weight radicals, and R5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.Type: GrantFiled: April 23, 2015Date of Patent: August 16, 2016Assignee: FXS Ventures, LLCInventor: Francis X. Smith
-
Patent number: 9308264Abstract: The present invention relates to improved ophthalmic solutions that employ select B vitamins; pyridoxine and its salts; and thiamine and its salts in order to more effectively preserve solutions and to reduce the degree to which cationic preservatives will deposit on contact lenses. Ophthalmic solutions are here understood to include contact lens treatment solutions, such as cleaners, soaking solutions, conditioning solutions and lens storage solutions, as well as wetting solutions and in-eye solutions for treatment of eye conditions.Type: GrantFiled: November 16, 2012Date of Patent: April 12, 2016Assignee: FXS VENTURES, LLCInventor: Francis X. Smith
-
Patent number: 9272066Abstract: The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: where R1, R2, R3 and R4 are —H or low molecular weight radicals, and R5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.Type: GrantFiled: February 14, 2014Date of Patent: March 1, 2016Assignee: FXS VENTURES, LLCInventor: Francis X. Smith
-
Patent number: 9149555Abstract: The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: where R1, R2, R3 and R4 are —H or low molecular weight radicals, and R5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.Type: GrantFiled: April 25, 2013Date of Patent: October 6, 2015Assignee: FXS Ventures, LLCInventor: Francis X. Smith
-
Patent number: 9078945Abstract: The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: where R1, R2, R3 and R4 are —H or low molecular weight radicals, and R5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.Type: GrantFiled: April 25, 2013Date of Patent: July 14, 2015Assignee: FXS VENTURES, LLCInventor: Francis X. Smith
-
Publication number: 20140163113Abstract: The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: where R1, R2, R3 and R4 are —H or low molecular weight radicals, and R5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.Type: ApplicationFiled: February 14, 2014Publication date: June 12, 2014Applicant: FXS Ventures, LLCInventor: Francis X. Smith
-
Patent number: 8691876Abstract: The present invention relates to a lens care solution having 0.001 to about 5 weight percent of a low molecular weight amine of the general formula: where R1, R2, R3 and R4 are —H or low molecular weight radicals, and R5 is a low molecular weight radical, or salt thereof; an effective amount of a tonicity agent; and the balance water.Type: GrantFiled: April 25, 2013Date of Patent: April 8, 2014Assignee: FXS Ventures, LLCInventor: Francis X. Smith
-
Publication number: 20140093472Abstract: The invention relates to an aqueous ophthalmic solution comprising 0.00001 to about 10.0 percent by weight L-histidine, 0.0001 to 3.0 percent by weight hydrogen peroxide, and optionally 0.1 to 500 parts per million of a preservative that provides superior preservative efficacy especially as against fungal microbes. These solutions may be employed in various ways including cleaning contact lenses, rinsing lenses while in the eye, storing lenses and in delivering active pharmaceutical agents to the eye.Type: ApplicationFiled: December 6, 2013Publication date: April 3, 2014Applicant: FXS Ventures, LLCInventor: Francis X. Smith